| Trial ID: | L4090 |
| Source ID: | NCT00633763
|
| Associated Drug: |
18f-Fallypride
|
| Title: |
PET-CT Scan Method to Monitor Pancreatic B-Cell Loss in Diabetes Mellitus
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type1 Diabetes Mellitus
|
| Interventions: |
DRUG: 18F-fallypride|DRUG: 18F-fallypride
|
| Outcome Measures: |
Primary: Difference in fallypride binding in the pancreas of long-standing T1DM patients versus healthy controls, At the end of the study when 12 controls and 12 patients have been studied. |
|
| Sponsor/Collaborators: |
Sponsor: University of California, Irvine | Collaborators: Juvenile Diabetes Research Foundation
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
30
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2008-02
|
| Completion Date: |
2008-07
|
| Results First Posted: |
|
| Last Update Posted: |
2009-05-29
|
| Locations: |
University of California Irvine Medical Center, Orange, California, 92868, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00633763
|
